Anticonvulsant properties of clobazam in a group of resistant epileptic patients
Hajnsek, F.; Hajnsek, S.
Lijecnicki Vjesnik 107(3-4): 127-131
1985
ISSN/ISBN: 0024-3477 PMID: 3982206 Document Number: 253191
Document emailed within 1 workday
Related Documents
Vajda, F.J.; Lewis, S.J.; Harris, Q.L.; Jarrott, B.; Young, N.A. 1987: Tolerance to the anticonvulsant effects of clonazepam and clobazam in the amygdaloid kindled rat Clinical and Experimental Neurology 23: 155-164Kokwaro, G.O.; Kwasa, T.O.; Indalo, A.A.; Kibwage, I.O. 1996: Steady-state anticonvulsant drug levels in epileptic patients East African Medical Journal 73(10): 679-682
Chien, C.; Keegan, D. 1972: Diazepam as an oral long-term anticonvulsant for epileptic mental patients Diseases of the Nervous System 33(2): 100-104
Hoikka, V.; Savolainen, K.; Karjalainen, P.; Alhava, E.M.; Sivenius, J. 1982: Treatment of osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy Annals of Clinical Research 14(2): 72-75
Kariks, J.; Perry, S.W.; Wood, D. 1971: Serum folic acid and phenytoin levels in permanently hospitalized epileptic patients receiving anticonvulsant drug therapy Medical Journal of Australia 2(7): 368-371
Callaghan, N.; Goggin, T. 1984: Clobazam as adjunctive treatment in drug resistant epilepsy--report on an open prospective study Irish Medical Journal 77(8): 240-244
Zaccara, G.; Galli, A.; Rossi, L.; Zappoli, R.; Zatelli, L.; Amaducci, L. 1977: Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment Rivista di Patologia Nervosa E Mentale 98(6): 363-375
Tsuchiya, S.; Maruyama, H.; Maruyama, K.; Fukuhara, M.; Maeda, R.; Kanematsu, S. 1985: A follow-up study of 1007 epileptic children with anticonvulsant therapy No to Hattatsu 17(1): 23-28
Deda, G.; Akinci, A.; Teziç, T.; Karagöl, U. 1992: Effects of anticonvulsant drugs on thyroid hormones in epileptic children Turkish Journal of Pediatrics 34(4): 239-244
Heldenberg, D.; Harel, S.; Holtzman, M.; Levtow, O.; Tamir, I. 1983: The effect of chronic anticonvulsant therapy on serum lipids and lipoproteins in epileptic children Neurology 33(4): 510-513
Testa, G.; Brunoro, N.; Giaretta, D. 1979: Hematic radio-immunologic monitoring of clonazepam: clinical-pharmacological evaluations in a group of epileptic patients Rivista di Neurologia 49(3): 259-267
Turkanis, S.A.; Cely, W.; Olsen, D.M.; Karler, R. 1974: Anticonvulsant properties of cannabidiol Research Communications in Chemical Pathology and Pharmacology 8(2): 231-246
Chu, N.S. 1988: Long-term ambulatory EEG evaluation of epileptic seizures and non-epileptic attacks: a study of 100 patients Zhonghua Yi Xue Za Zhi 42(5): 359-366
Palmer, G.C.; Murray, R.J.; Cramer, C.L.; Stagnitto, M.L.; Knowles, M.K.; Freedman, L.R.; Eismann, M.S.; Mahmood, N.; Balestra, M.; Borrelli, A.R.; Hudzik, T.J.; McCarthy, D.J. 1999: S]-AR-R 15896AR-A novel anticonvulsant: acute safety, pharmacokinetic and pharmacodynamic properties Journal of Pharmacology and Experimental Therapeutics 288(1): 121-132
Ezcurdia, L.; Jovtis, S.L.; Mickiewicz, E.; Temperley, G.; Rondinón, M.; Blajman, C.; Cóppola, F.S.; Lewi, D.; Cazap, E.; Breier, S.; Fasce, H.; Fein, L.; Polera, J.; Triguboff, E.; Uranga, G.; Pasccón, G.; Luchina, A.M.; Martínez, C.A.; Politi, P.M.; Rubio, G.; Alvarez, A.M. 1997: Paclitaxel in platinum-resistant ovarian cancer patients. Argentine Multicenter Taxol Group Seminars in Oncology 24(5 Suppl. 15): S15
Lange, J.; Rump, S.; Ilczuk, I.; Lapszewicz, J.; Rabsztyn, T.; Walczyna, K. 1977: Synthesis and properties of cyclic derivatives of succinic acid with anticonvulsant activity Die Pharmazie 32(10): 579-581
Obniska, J.; Zejc, A. 2003: Synthesis, physicochemical and anticonvulsant properties of some n-substituted amides of 3-spirocycloalkylpyrrolidine-2,5-dione Acta Poloniae Pharmaceutica 60(5): 383-390
Shapovalova, V.O.; Shapovalov, V.V. 1998: Spasmophilia in children and the anticonvulsant properties of a new Ukrainian preparation containing a pyrimidine derivative Fiziolohichnyi Zhurnal 44(5-6): 102-105
Kamiński, K.; Obniska, J. 2008: Synthesis and anticonvulsant properties of new 1-(2-pyridinyl)- 3-substituted pyrrolidine-2,5-dione derivatives Acta Poloniae Pharmaceutica 65(4): 457-465
Dimmock, J.R.; Puthucode, R.N.; Lo, M.S.; Quail, J.W.; Yang, J.; Stables, J.P. 1996: Structural modifications of the primary amino group of anticonvulsant aryl semicarbazones Die Pharmazie 51(2): 83-88